Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Canciani

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|April 22, 1985
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calciumM Cattaneo, M T Canciani, P M Mannucci
Scandinavian Journal of Haematology|May 1, 1979
The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulantP M Mannucci, M T Canciani, D Mari, et al.
British Journal of Haematology|February 1, 1981
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's diseaseP M Mannucci, M T Canciani, L Rota, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1980
Inherited deficiency of antithrombin III in an Italian kindredA Tripodi, C Boyer, M T Canciani, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand diseaseL Baronciani, A B Federici, G Cozzi, et al.
Blood|October 9, 1998
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approachesA B Federici, F Stabile, G Castaman, et al.
Blood|October 25, 2001
Changes in health and disease of the metalloprotease that cleaves von Willebrand factorP M Mannucci, M T Canciani, I Forza, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma)P M Mannucci, M Cattaneo, M T Canciani, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen bindingL Baronciani, A B Federici, M Beretta, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2012
A comparative evaluation of a new automated assay for von Willebrand factor activityA S Lawrie, F Stufano, M T Canciani, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|April 22, 1985
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calciumM Cattaneo, M T Canciani, P M Mannucci
Scandinavian Journal of Haematology|May 1, 1979
The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulantP M Mannucci, M T Canciani, D Mari, et al.
British Journal of Haematology|February 1, 1981
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's diseaseP M Mannucci, M T Canciani, L Rota, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1980
Inherited deficiency of antithrombin III in an Italian kindredA Tripodi, C Boyer, M T Canciani, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand diseaseL Baronciani, A B Federici, G Cozzi, et al.
Blood|October 9, 1998
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approachesA B Federici, F Stabile, G Castaman, et al.
Blood|October 25, 2001
Changes in health and disease of the metalloprotease that cleaves von Willebrand factorP M Mannucci, M T Canciani, I Forza, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma)P M Mannucci, M Cattaneo, M T Canciani, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen bindingL Baronciani, A B Federici, M Beretta, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2012
A comparative evaluation of a new automated assay for von Willebrand factor activityA S Lawrie, F Stufano, M T Canciani, et al.
Pageof 3